🟡

Milk Thistle × Tricyclic Antidepressants

MODERATE INTERACTION

⚠️ Mechanism

Milk Thistle is a weak inhibitor of CYP3A4, which decreases metabolism of CYP3A4 substrates, potentially increasing their plasma concentrations and risk of adverse effects.

📋 Effect

Increased plasma levels of amitriptyline (tricyclic-antidepressants), potentially leading to toxicity or enhanced adverse effects.

💊 Management

Monitor for increased adverse effects of amitriptyline. Dose reduction may be necessary. Consider alternative supplement or consult healthcare provider.

Plain Language Summary

This combination may be moderately risky because milk thistle can slow down how your body breaks down tricyclic antidepressants. This can lead to higher levels of the medication building up in your system, which may increase your risk of side effects.

Source

Flockhart CYP450 Table (drug-interactions.medicine.iu.edu)

Supporting Research

Evaluation of the effect of herbal agents as management of radiodermatitis in breast cancer patients: A systematic review and meta-analysis PMID:37816677 DOI:10.1111/jjns.12559 2024
Efficacy of different interventions for nonalcoholic fatty liver disease: A meta-analysis of lifestyle modifications, silymarin, and medications PMID:40738719 DOI:10.6133/apjcn.202508_34(4).0003 2025
Pharmacotherapy for trichotillomania PMID:34582562 DOI:10.1002/14651858.CD007662.pub3 2021
Efficacy of traditional Chinese medicine combined with Silibinin on nonalcoholic fatty liver disease: A meta-analysis and systematic review PMID:38306552 DOI:10.1097/MD.0000000000037052 2024
Are alterations needed in Silybum marianum (Silymarin) administration practices? A novel outlook and meta-analysis on randomized trials targeting liver injury PMID:40221681 DOI:10.1186/s12906-025-04886-y 2025
The therapeutic effects of silymarin for patients with glucose/lipid metabolic dysfunction: A meta-analysis PMID:33019400 DOI:10.1097/MD.0000000000022249 2020
The therapeutic effect of silymarin in the treatment of nonalcoholic fatty disease: A meta-analysis (PRISMA) of randomized control trials PMID:29245314 DOI:10.1097/MD.0000000000009061 2017
Prevention and management of idiosyncratic drug-induced liver injury: Systematic review and meta-analysis of randomised clinical trials PMID:33359912 DOI:10.1016/j.phrs.2020.105404 2021
Medical Disclaimer: This interaction record is for informational and educational purposes only and does not constitute medical advice. Drug-supplement interactions can be dangerous. Always consult your healthcare provider or pharmacist before combining any supplement with prescription medications. Do not stop or change any medication without professional guidance.